Shopping Cart
Your Cart is Empty
Quantity:
Subtotal
Taxes
Shipping
Total
There was an error with PayPalClick here to try again
CelebrateThank you for your business!You should be receiving an order confirmation from Paypal shortly.Exit Shopping Cart

Arden Med Spa

Qsymia

Qsymia for Weight Loss

Only those with a BMI of 27 or higher were eligible for treatment. You must also have at least one weight-related illness, such as high blood pressure, type 2 diabetes, or high cholesterol. (Not sure about BMI? Use this tool to find out where you are in the world.)

Qsymia is a drug that combines two FDA-approved drugs: phentermine and topiramate. Topiramate treats seizures in people with epilepsy or migraines, and phentermine helps with short-term weight loss.

Qsymia is safe?

Medications must be tested in a laboratory, animal, and human before being approved- by the FDA. The drug business tested the effectiveness of Qsymia in two human studies on 3,700 obese and overweight patients after laboratory and animal tests. Patients lost an average of 6.7-8.9% of their body weight after one year of treatment.


No need. According to the FDA, users should follow a low-calorie diet in addition to the prescribed daily doses of 7.5 milligrams of phentermine and 46 milligrams of topiramate and exercise regularly. The researchers were also asked to change their lifestyle by eating healthier and exercising more. Those who do not lose at least 5% of their body weight after 12 weeks should stop taking Qysmia.

Weight loss near me

Qsymia, the first of four newly approved weight loss drugs, was the most effective drug that helped patients lose 5% of their body weight.

 An average of 75 percent of Qsymia beneficiaries, 63 percent of Saxon beneficiaries, and 55 percent of Contrave beneficiaries lost 5 percent of their body weight. 

In the experiment, an average of 49% of those taking Belvig and 44% of those taking Alli without a prescription lost 5% of their body weight. On average, 23% of those taking a placebo pill lost 5% of their body weight.


One year later, participants taking Qsymia lost an average of 8.8 kilograms or slightly less than 20 kilograms. 

The average weight loss for Saxon recipients was 5.3 kilograms (11.5 pounds) for Contrave recipients, it was 5 kilograms (11 pounds) for Belvig recipients, it was 3.2 kilograms (7 pounds)- and for Orlistat recipients- it was 2.6 kilograms (5.5 pounds).

Qsymia is neither the best nor the worst of the five slimming treatments available. 

In a recent study, Belvig and Alli were associated with the fewest reported side effects. 

The worst side effects were Saxenda and Contrave, while Qsymia was in the middle. 

According to the Arden Med Spa, the likelihood of adverse reactions did not differ statistically from those taking Qsymia, Saxenda, or Contrave.

According to existing research, doctors and their patients have different factors to consider when choosing a drug for weight loss, as well as different strengths and weaknesses between the proposed treatments.

 Saxenda, a diabetes drug that started its life in the pharmaceutical industry, maybe the best choice for obese patients with metabolic disorders. 

Contrave, which combines the antidepressant bupropion with the antidepressant naltrexone, can be problematic for people struggling with substance abuse.

BMI( Weight calculator)